Adams R J, McKie V C, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols F T, Bonds D R, Brambilla D
Department of Neurology, Medical College of Georgia, Augusta 30912-3200, USA.
N Engl J Med. 1998 Jul 2;339(1):5-11. doi: 10.1056/NEJM199807023390102.
Blood transfusions prevent recurrent stroke in children with sickle cell anemia, but the value of transfusions in preventing a first stroke is unknown. We used transcranial Doppler ultrasonography to identify children with sickle cell anemia who were at high risk for stroke and then randomly assigned them to receive standard care or transfusions to prevent a first stroke.
To enter the study, children with sickle cell anemia and no history of stroke had to have undergone two transcranial Doppler studies that showed that the time-averaged mean blood-flow velocity in the internal carotid or middle cerebral artery was 200 cm per second or higher. The patients were randomly assigned to receive standard care or transfusions to reduce the hemoglobin S concentration to less than 30 percent of the total hemoglobin concentration. The incidence of stroke (cerebral infarction or intracranial hemorrhage) was compared between the two groups.
A total of 130 children (mean [+/-SD] age, 8.3+/-3.3 years) were enrolled; 63 were randomly assigned to receive transfusions and 67 to receive standard care. At base line, the transfusion group had a slightly lower mean hemoglobin concentration (7.2 vs. 7.6 g per deciliter, P=0.001) and hematocrit (20.4 vs. 21.7 percent, P=0.002). Ten patients dropped out of the transfusion group, and two patients crossed over from the standard-care group to the transfusion group. There were 10 cerebral infarctions and 1 intracerebral hematoma in the standard-care group, as compared with 1 infarction in the transfusion group -- a 92 percent difference in the risk of stroke (P<0.001). This result led to the early termination of the trial.
Transfusion greatly reduces the risk of a first stroke in children with sickle cell anemia who have abnormal results on transcranial Doppler ultrasonography.
输血可预防镰状细胞贫血患儿复发性中风,但输血在预防首次中风方面的价值尚不清楚。我们使用经颅多普勒超声检查来识别有中风高风险的镰状细胞贫血患儿,然后将他们随机分配接受标准治疗或输血以预防首次中风。
为纳入研究,无中风病史的镰状细胞贫血患儿必须接受过两次经颅多普勒检查,结果显示颈内动脉或大脑中动脉的时间平均平均血流速度为每秒200厘米或更高。患者被随机分配接受标准治疗或输血,以使血红蛋白S浓度降低至总血红蛋白浓度的30%以下。比较两组中风(脑梗死或颅内出血)的发生率。
共纳入130名儿童(平均[±标准差]年龄,8.3±3.3岁);63名被随机分配接受输血,67名接受标准治疗。基线时,输血组的平均血红蛋白浓度(7.2比7.6克/分升,P = 0.001)和血细胞比容(20.4比21.7%,P = 0.002)略低。输血组有10名患者退出,2名患者从标准治疗组转入输血组。标准治疗组有10例脑梗死和1例脑内血肿,而输血组有1例梗死——中风风险相差92%(P<(此处原文有误,推测应为P<0.001))。这一结果导致试验提前终止。
对于经颅多普勒超声检查结果异常的镰状细胞贫血患儿,输血可大大降低首次中风的风险。